Form 4: Solid Biosciences' Chief Medical Officer Reports Stock Transactions
SEC Form 4 Filing
Gabriel Brooks, Chief Medical Officer of Solid Biosciences, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On February 13, 2025, Gabriel Brooks, the Chief Medical Officer of Solid Biosciences Inc., acquired 10,937 shares of common stock through the vesting of restricted stock units.
- Following this transaction, Brooks directly owns 26,068 shares of common stock.
- On February 14, 2025, Brooks sold 3,256 shares of common stock at a price of $3.96 per share.
- This sale resulted in Brooks holding 22,812 shares of common stock directly.
- The sale on February 14, 2025, was to cover withholding taxes related to the vesting of RSUs, according to a pre-arranged sales instruction letter adopted on August 15, 2024.
- Following the reported transactions, Brooks directly owns 32,813 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company insider, with no inherently positive or negative implications.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Dr. Brooks adopted a durable automatic sales instruction letter. |
| 02/13/2024 | The RSUs were granted (the 'Grant Date') and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary. |
| 02/13/2025 | Brooks acquired 10,937 shares of common stock through RSU vesting. |
| 02/14/2025 | Brooks sold 3,256 shares of common stock at $3.96 per share. |
| 02/18/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.